New radiation approach targets cancer in the brain and spine
NCT ID NCT06910761
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This Phase II trial tests whether a precise type of radiation called photon VMAT craniospinal irradiation can help people with breast or lung cancer that has spread to the fluid and lining around the brain and spinal cord. About 35 adults with this condition will receive radiation to the entire brain and spine. Researchers will measure how long the cancer stays under control in the central nervous system and how patients' quality of life changes.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- photon volumetric modulated arc radiotherapy (VMAT) craniospinal irradiation
- What this could lead to
- If successful, this could provide an effective radiation-based treatment option for cancer that has spread to the fluid and lining around the brain and spinal cord.
- What could go wrong
- This is a small, early-phase trial with only 35 participants, so results may not apply to everyone. Radiation to the brain and spine can cause side effects like fatigue, nausea, and neurological symptoms.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANATOMIC STAGE IV BREAST CANCER AJCC V8 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
City of Hope Medical Center
RECRUITINGDuarte, California, 91010, United States
-
City of Hope at Irvine Lennar
RECRUITINGIrvine, California, 92618, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Facing the fear: a new program aims to ease anxiety in advanced cancer
- Can a Chemo-Immunotherapy duo outsmart tough lung cancer?
- Digital therapy aims to tame the fear that haunts cancer survivors
- Engineered immune cells join chemo and antibody to attack Hard-to-Treat breast cancer
- Could a gentler chemo work for older breast cancer patients?
- Genetic clues in blood and tumors could personalize breast cancer care